Novo Holdings and Healthcap launch new biotech firm
Novo Holdings is playing a crucial role in the establishment of the new biotech firm Tribune Therapeutics which will exploit a new pan-antifibrotic mechanism across a wide range of indications.
BY ANDREAS LØNSTRUP, TRANSLATED BY NIELSINE NIELSEN
Holdings company Novo Nordisk has established a new biotech firm, Tribune Therapeutics, according to a company press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
